Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Fifth Chamber) of 19 June 2018 –  
Tillotts Pharma v EUIPO — Ferring (XENASA)

(Case T‑362/16)

(EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

| 1. | EU trade mark—Definition and acquisition of the EU trade mark—Relative grounds for refusal—Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services—Likelihood of confusion with the earlier mark—Criteria for assessment  (Council Regulation No 207/2009, Art. 8(1)(b))  (see paras 17, 19, 60) |

| 2. | EU trade mark—Definition and acquisition of the EU trade mark—Relative grounds for refusal—Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services—Likelihood of confusion with the earlier mark—Refusal to register on a ground relating to refusal even limited to part of the Union  (Council Regulation No 207/2009, Art. 8(1)(b))  (see para. 18) |

| 3. | EU trade mark—Definition and acquisition of the EU trade mark—Relative grounds for refusal—Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services—Similarity of the marks concerned—Criteria for assessment  (Council Regulation No 207/2009, Art. 8(1)(b))  (see para. 26) |

| 4. | EU trade mark—Definition and acquisition of the EU trade mark—Relative grounds for refusal—Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services—Likelihood of confusion with the earlier mark—Word marks XENASA and PENTASA  (Council Regulation No 207/2009, Art. 8(1)(b))  (see paras 41-43, 50-53, 57, 58, 68-71) |

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 29 April 2016 (Case R 3264/2014-4), relating to opposition proceedings between Ferring and Tillotts Pharma.

Operative part

The Court:

| 1. | Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 29 April 2016 (Case R 3264/2014-4); |

| 2. | Orders EUIPO to bear its own costs and to pay those incurred by Tillotts Pharma AG; |

| 3. | Orders Ferring BV to bear its own costs. |

[Top](#document1)